Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus
Tóm tắt
The endothelium plays a pivotal role in modulating the reactivity of vascular smooth muscle through the formation of several vasoactive substances. We examined the effects of endothelium-dependent and independent vasodilators on forearm blood flow in 29 patients with Type 2 (non-insulin-dependent) diabetes mellitus and in 21 control subjects, using venous occlusion plethysmography. Via a brachial artery cannula, increasing amounts of acetylcholine and glyceryl trinitrate were infused in doses of 60, 120, 180 and 240 mmol per min and 3, 6 and 9 nmol per min respectively. NG monomethyl-l-arginine, a stereospecific inhibitor of endothelium derived relaxing factor, was infused to inhibit basal and stimulated release of this dilator substance. Reactive hyperaemic forearm blood flow did not differ between groups. Forearm blood flow responses to each dose of acetylcholine were significantly greater in control than diabetic subjects (p<0.01 for all doses). NG monomethyl-l-arginine attenuated forearm blood flow from maximal stimulated values when responses were compared with the natural decline to acetylcholine in forearm flow in both control and diabetic subjects (p<0.05 for both groups), but had no effect on basal blood flow responses. Forearm blood flow responses to each dose of glyceryl trinitrate were significantly greater in control than diabetic subjects (p<0.05 for all). These data provide evidence for endothelial and smooth muscle dysfunction in diabetes which may have important therapeutic implications.
Tài liệu tham khảo
Ganda OP (1980) Pathogenesis of macrovascular disease in the human diabetic. Diabetes 29: 931–942
Colwell JA, Lopes-Virella M, Halushka PV (1981) Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 4: 121–133
Ruderman NB, Haudenschild C (1984) Diabetes as an atherogenic factor. Prog Cardiovasc Dis 26: 373–412
Steiner G (1981) Diabetes and atherosclerosis. Diabetes 30 [Suppl 2]: 1–7
Jensen T, Feldt-Rasmussen B, Bjerre-Knudsen J, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet II: 461–463
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526
Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG (1990) Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble s-nitrosocysteine than nitric oxide. Nature 345: 161–163
Griffith TM, Lewis MJ, Newby AC, Henderson AH (1988) Endothelium-derived relaxing factor. J Am Coll Cardiol 12: 797–806
Vane JR, Anggard EE, Botting RM (1990) Regulatory functions of the vascular endothelium. N Engl J Med 323: 27–36
Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22–27
Creager MA, Cooke JP, Mendelsohn ME et al. (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228–234
Cohen RA, Zitnay KM, Haudenschild CL, Cunningham LD (1988) Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 63: 903–910
Davis MD, Hubbard LD, Trautman J, Klein R (1985) Studies of retinopathy. Methodology for assessment and classification with fundus photographs. Diabetes 34 [Suppl3]: 42–49
Sternberg JC (1977) A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 23: 1456–1464
Bloom S, Till S, Sönksen P, Smith S (1984) Use of a biothesiometer to measure vibration thresholds and their variation in 519 non-diabetic subjects. BMJ 288: 1793–1795
O'Brien IAD, O'Hare JP, Lewin IG, Corrall RJM (1986) The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability. Quart J Med 61: 957–967
Whitney RJ (1953) The measurement of volume changes in human limbs. J Physiol (Lond) 121: 1–27
Edwards G, Weston AH (1990) Potassium channel openers and vascular smooth muscle relaxation. Pharmac Ther 48: 237–258
Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333: 664–666
Rees DD, Palmer RMJ, Moncada S (1989) Role of endotheliumderived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 86: 3375–3378
Johns RA, Peach MJ, Linden J, Tichotsky A (1990) NG monomethyl l-arginine inhibits endothelium-derived relaxing factorstimulated cyclic GMP accumulation in cocultures of endothelial and vascular smooth muscle cells by an action specific to the endothelial cell. Circ Res 67: 979–985
Vallance P, Collier J, Moncada S (1989) Effects of endotheliumderived nitric oxide on peripheral arteriolar tone in man. Lancet II: 997–1000
Paterson GC, Whelan RF (1955) Reactive hyperaemia in the human forearm. Clin Sci 14: 197–211
Yasue H, Matsuyama K, Matsuyama K, Okumara K, Morikami Y, Ogawa H (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 81: 482–490
Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87: 432–438
Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1–21
Colwell JA, Lopes-Virella MF (1988) A review of the development of large vessel disease in diabetes mellitus. Am J Med 28: 113–118